Top Markets
Coin of the day
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals, Inc.

PARD
株式のランク #42765
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the... Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and market introduction of cancer treatments. Its flagship product candidate, Picoplatin, is a platinum-based therapy targeting various cancer types, such as small cell lung, colorectal, prostate, and ovarian cancers. The company has advanced Picoplatin through several clinical stages, including a pivotal Phase III SPEAR trial for small cell lung cancer patients in a second-line treatment setting. Furthermore, Phase II studies investigated Picoplatin as an initial therapy for metastatic colorectal cancer and hormone-refractory prostate cancer. An early-stage Phase I trial also examined an oral formulation of Picoplatin for solid tumors. Founded in 1984 as NeoRx Corporation, the company rebranded to Poniard Pharmaceuticals, Inc. in September 2006 and operates from its base in Seattle, Washington.
株価
$0.0001
最終同期: 2026-08-11
時価総額
$150.00
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Poniard Pharmaceuticals, Inc. (PARD)

カテゴリー

Poniard Pharmaceuticals, Inc.(PARD)の株価履歴
終値の最高値: $0.00 (2026-08-01)

終値の最安値: $1.69K (1988-08-01)
Poniard Pharmaceuticals, Inc. の株価履歴(1988 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 -99.00%
2022 0.00%
2021 -73.59%
2020 68.39%
2019 -58.15%
2018 0.25%
2017 -41.00%
2016 2.48%
2015 -45.77%
2014 -26.13%
2013 -32.03%
2012 -90.08%
2011 -82.25%
2010 -77.28%
2009 282.90%
2008 -55.38%
2007 -20.51%
2006 12.16%
2005 -57.29%
2004 -54.54%
2003 688.74%
2002 -88.91%
2001 -12.65%
2000 77.36%
1999 162.56%
1998 -76.29%
1997 24.18%
1996 -29.30%
1995 19.35%
1994 -39.86%
1993 -35.31%
1992 -11.37%
1991 687.42%
1990 -85.32%
1989 -41.53%
1988 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.08K -7.22%
KR